NYSE:USNA - USANA Health Sciences Stock Price, Forecast & News

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

USANA Health Sciences announced that its Board of Directors has approved a stock repurchase program on Tuesday, October 23rd 2018, which authorizes the company to buyback $150,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to repurchase up to 5.9% of its stock through open market purchases. Stock buyback programs are generally a sign that the company's board believes its stock is undervalued.

USANA Health Sciences, Inc. (NYSE:USNA) issued its earnings results on Tuesday, October, 22nd. The company reported $1.09 EPS for the quarter, topping the consensus estimate of $0.87 by $0.22. The company earned $260.60 million during the quarter, compared to analyst estimates of $256.22 million. USANA Health Sciences had a net margin of 9.38% and a return on equity of 27.60%. The company's revenue was down 12.2% compared to the same quarter last year. During the same period last year, the firm posted $1.24 EPS. View USANA Health Sciences' Earnings History.

USANA Health Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for USANA Health Sciences.

USANA Health Sciences will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

4 brokers have issued 12-month target prices for USANA Health Sciences' stock. Their forecasts range from $65.00 to $75.00. On average, they expect USANA Health Sciences' stock price to reach $70.00 in the next year. This suggests a possible upside of 7.5% from the stock's current price. View Analyst Price Targets for USANA Health Sciences.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for USANA Health Sciences.

News headlines about USNA stock have trended extremely negative recently, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. USANA Health Sciences earned a media sentiment score of -4.3 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for USANA Health Sciences.

USANA Health Sciences saw a drop in short interest during the month of December. As of December 31st, there was short interest totalling 1,410,000 shares, a drop of 6.6% from the December 15th total of 1,510,000 shares. Based on an average daily trading volume, of 119,900 shares, the days-to-cover ratio is presently 11.8 days. Approximately 11.7% of the company's stock are short sold. View USANA Health Sciences' Current Options Chain.

Some companies that are related to USANA Health Sciences include Estee Lauder Companies (EL), Herbalife Nutrition (HLF), Avon Products (AVP), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), Nu Skin Enterprises (NUS), Revlon (REV), Medifast (MED), Veru (VERU) and Nature's Sunshine Products (NATR).

Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include IBM (IBM), Gilead Sciences (GILD), Allergan (AGN), Amgen (AMGN), Intel (INTC), Ionis Pharmaceuticals (IONS), Tesla (TSLA), Western Digital (WDC), AbbVie (ABBV) and Abbott Laboratories (ABT).

USANA Health Sciences' stock is owned by many different of retail and institutional investors. Top institutional shareholders include California Public Employees Retirement System (0.26%), New York State Teachers Retirement System (0.06%), 6 Meridian (0.06%), Strs Ohio (0.05%), State of Alaska Department of Revenue (0.04%) and Arizona State Retirement System (0.04%). Company insiders that own USANA Health Sciences stock include Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Paul A Jones, Robert A Sinnott, Robert Auciaux and Walter Noot. View Institutional Ownership Trends for USANA Health Sciences.

USNA stock was sold by a variety of institutional investors in the last quarter, including Arizona State Retirement System, Dupont Capital Management Corp, Strs Ohio, Louisiana State Employees Retirement System and State of Alaska Department of Revenue. Company insiders that have sold USANA Health Sciences company stock in the last year include Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, Joshua Foukas, Myron W Wentz, Robert Auciaux and Walter Noot. View Insider Buying and Selling for USANA Health Sciences.

USNA stock was bought by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, New York State Teachers Retirement System, FNY Investment Advisers LLC, SG Americas Securities LLC, Janney Montgomery Scott LLC and 6 Meridian. Company insiders that have bought USANA Health Sciences stock in the last two years include Global Ltd Gull and Myron W Wentz. View Insider Buying and Selling for USANA Health Sciences.

Shares of USNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of USNA stock can currently be purchased for approximately $65.10.

USANA Health Sciences has a market capitalization of $1.41 billion and generates $1.19 billion in revenue each year. The company earns $126.22 million in net income (profit) each year or $5.16 on an earnings per share basis. USANA Health Sciences employs 1,911 workers across the globe.View Additional Information About USANA Health Sciences.

The official website for USANA Health Sciences is http://www.usana.com/.

USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company can be reached via phone at 801-954-7100 or via email at [email protected]